Fermenta Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 112.64 | 127.86 | 125.92 |
| Operating Expense | 84.15 | 96.49 | 89.36 |
| Net Profit | 14.72 | 16.23 | 29.31 |
| Net Profit Margin | 13.07 | 12.69 | 23.28 |
| Earning Per Share | 5.05 | 5.57 | 10.05 |
| EBIDTA | 26.16 | 28.89 | 42.88 |
| Effective Tax Rate | 13.06 | 12.75 | 13.62 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 112.64 |
| Operating Expense | 84.15 |
| Net Profit | 14.72 |
| Net Profit Margin | 13.07 |
| Earning Per Share | 5.05 |
| EBIDTA | 26.16 |
| Effective Tax Rate | 13.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 430.53 | 307.09 | 328.91 |
| Operating Expenses Annual | 330.42 | 270.10 | 290.48 |
| Operating Profit Annual | 111.79 | 36.14 | -12.69 |
| Interest Annual | 14.20 | 17.05 | 20.80 |
| Depreciation | 20.01 | 20.51 | 21.40 |
| Net Profit Annual | 67.62 | -18.74 | -57.00 |
| Tax Annual | 6.81 | 14.14 | -0.97 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 430.53 |
| Operating Expenses Annual | 330.42 |
| Operating Profit Annual | 111.79 |
| Interest Annual | 14.20 |
| Depreciation | 20.01 |
| Net Profit Annual | 67.62 |
| Tax Annual | 6.81 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 13.56 | 14.54 | -4.49 |
| Cash Flow from Operations | 33.83 | 105.02 | 123.75 |
| Cash Flow from Investing | 0.41 | -15.15 | -63.47 |
| Cash Flow from Financing | -50.91 | -90.86 | -41.25 |
| Cash Flow at the End | -3.12 | 13.56 | 14.54 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 13.56 |
| Cash Flow from Operations | 33.83 |
| Cash Flow from Investing | 0.41 |
| Cash Flow from Financing | -50.91 |
| Cash Flow at the End | -3.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 26.11 | 14.92 | 14.52 |
| PBIT Margin (%) | 20.73 | 7.20 | 7.07 |
| PBT Margin (%) | 19.33 | 6.79 | 6.74 |
| Net PROFIT Margin (%) | 15.71 | -6.10 | -17.33 |
| Return On Networth / Equity (%) | 19.48 | -2.38 | 0.84 |
| Return On Networth /Employed (%) | 17.61 | 4.10 | 3.77 |
| Return On Assets (%) | 13.35 | -3.48 | -9.18 |
| Total Debt / Equity (X) | 0.37 | 0.55 | 0.63 |
| Asset Turnover Ratio (%) | 0.85 | 0.57 | 0.53 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 26.11 |
| PBIT Margin (%) | 20.73 |
| PBT Margin (%) | 19.33 |
| Net PROFIT Margin (%) | 15.71 |
| Return On Networth / Equity (%) | 19.48 |
| Return On Networth /Employed (%) | 17.61 |
| Return On Assets (%) | 13.35 |
| Total Debt / Equity (X) | 0.37 |
| Asset Turnover Ratio (%) | 0.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 222.65 | 261.40 | 231.23 |
| Total Current Assets Annual | 320.52 | 238.23 | 253.32 |
| Non Current Assets Annual | 301.95 | 326.35 | 410.54 |
| Total Shareholders Funds Annual | 379.95 | 314.23 | 336.06 |
| Total Assets Annual | 622.47 | 564.58 | 663.86 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 222.65 |
| Total Current Assets Annual | 320.52 |
| Non Current Assets Annual | 301.95 |
| Total Shareholders Funds Annual | 379.95 |
| Total Assets Annual | 622.47 |
EPS (INR)
Expected
6.49
Reported
6.48
Surprise
-0.15%
Jun 2025
EPS beaten by -0.15%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
